Case number 2019-1368
Sanofi-Aventis Deutschland v. Mylan Pharmaceuticals Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | SANOFI-AVENTIS DEUTSCHLAND v. MYLAN PHARMACEUTICALS INC. [OPINION - NONPRECEDENTIAL] [nonprecedential] (0) |
| Apr 23, 2021 | 0 | SANOFI-AVENTIS DEUTSCHLAND v. MYLAN PHARMACEUTICALS INC. [ERRATA] [nonprecedential] (0) |
| Oct 5, 2020 | 80 | The petition for writ of certiorari, No. 19-1451, filed on 06/26/2020, was Denied on 10/05/2020. [726659] [JAB] [Entered: 10/05/2020 04:01 PM] (0) |
| Jul 6, 2020 | 79 | Petition for writ of Certiorari filed on 06/26/2020, and placed on the docket 07/02/2020, in the Supreme Court of the United States. Supreme Court #: 19-1451, Sanofi-Aventis Deutschland GmbH v. Mylan Pharmaceuticals Inc. [705563] [JAB] [Entered: 07/06/2020 02:42 PM] (0) |
| Feb 18, 2020 | 78 | Mandate issued to the United States Patent and Trademark Office. Service as of this date by the Clerk of Court. [671868] [19-1368, 19-1369] [MJL] [Entered: 02/18/2020 08:15 AM] (0) |
| Feb 14, 2020 | 77 | Clerk's Note to the File: The Supreme Court entered the following on 02/14/2020: "The order heretofore issued by The Chief Justice on February 10, 2020, is vacated. The application for a stay is, in all respects, denied." [671629] [MJL] [Entered: 02/14/2020 03:28 PM] (0) |
| Feb 11, 2020 | 76 | MODIFIED ENTRY: Order from the Supreme Court of the United States staying issuance of mandate. [670276]--[Edited 02/11/2020 by JAB to revise docket text] [JCP] [Entered: 02/11/2020 12:59 PM] (0) |
| Feb 6, 2020 | 74 | REPLY of Appellant Sanofi-Aventis Deutschland GmbH to response [73]. Service: 02/06/2020 by email. [668931] [19-1368] [Elizabeth Weiswasser] [Entered: 02/06/2020 11:23 AM] (0) |
| Feb 6, 2020 | 75 | ORDER filed denying [72] motion to stay mandate filed by Sanofi-Aventis Deutschland GmbH. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [668940] [JAB] [Entered: 02/06/2020 11:39 AM] (0) |
| Feb 4, 2020 | 73 | RESPONSE of Appellee Mylan Pharmaceuticals Inc. to the motion [72] filed by Appellant Sanofi-Aventis Deutschland GmbH. Service: 02/04/2020 by email. [668184] [19-1368] [Richard Torczon] [Entered: 02/04/2020 10:38 AM] (0) |
| Jan 31, 2020 | 72 | MOTION of Appellant Sanofi-Aventis Deutschland GmbH to stay execution of the mandate until the Supreme Court decides on the forthcoming Writ of Certiorari. [Consent: opposed]. Service: 01/31/2020 by email. [667790] [19-1368] [Elizabeth Weiswasser] [Entered: 01/31/2020 07:16 PM] (0) |
| Jan 30, 2020 | 71 | **TEXT ONLY** ORDER granting motion to withdraw attorney Aaron L.J. Pereira [70] filed by Appellant Sanofi-Aventis Deutschland GmbH. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [667158] [JAB] [Entered: 01/30/2020 08:10 AM] (0) |
| Jan 29, 2020 | 70 | MOTION of Appellant Sanofi-Aventis Deutschland GmbH to withdraw counsel Aaron L.J. Pereira [Consent: unopposed]. Service: 01/29/2020 by email. [667058] [19-1368] [Elizabeth Weiswasser] [Entered: 01/29/2020 03:49 PM] (7) |
| Jan 28, 2020 | 69 | ORDER filed denying [63] petition for panel rehearing, for en banc rehearing filed by Sanofi-Aventis Deutschland GmbH; denying [66] petition for panel rehearing filed by Mylan Pharmaceuticals Inc. By: En Banc (Per Curiam). Service as of this date by the Clerk of Court. [666498] [JAB] [Entered: 01/28/2020 01:10 PM] (2) |
| Dec 26, 2019 | 68 | 3 paper copies of the petition for panel rehearing [66] received from Appellee Mylan Pharmaceuticals Inc. [658749] [JAB] [Entered: 12/26/2019 10:03 AM] (0) |
| Dec 23, 2019 | 67 | 18 paper copies of the combined petition for panel rehearing and rehearing en banc [63] received from Sanofi-Aventis Deutschland GmbH. [658454] [MJL] [Entered: 12/23/2019 12:14 PM] (0) |
| Dec 20, 2019 | 66 | Petition for panel rehearing filed by Appellee Mylan Pharmaceuticals Inc.. Service: 12/20/2019 by email. The paper copies of the petition must be filed within two business days (see Fed. Cir. R. 35(c)(4).The required paper copies should be received by the court on or before 12/26/2019 [658345] [19-1368] [Douglas Carsten] [Entered: 12/20/2019 05:39 PM] (43) |
| Dec 20, 2019 | 65 | NOTICE OF NON-COMPLIANCE: The submission of Mylan Pharmaceuticals Inc., Petition for Panel Rehearing [64], is not in compliance with the rules of this court (see attached). Compliant document due 12/31/2019. Service as of this date by the Clerk of Court. [657991] [MJL] [Entered: 12/20/2019 08:39 AM] (1) |
| Dec 19, 2019 | 64 | Petition for panel rehearing filed by Appellee Mylan Pharmaceuticals Inc.. Service: 12/19/2019 by email. The paper copies of the petition must be filed within two business days (see Fed. Cir. R. 35(c)(4).The required paper copies should be received by the court on or before 12/23/2019 [657974] [19-1368] [Douglas Carsten] [Entered: 12/19/2019 06:49 PM] (14) |
| Dec 19, 2019 | 63 | Petition for panel rehearing, for en banc rehearing filed by Appellant Sanofi-Aventis Deutschland GmbH. Service: 12/19/2019 by email. The paper copies of the petition must be filed within two business days (see Fed. Cir. R. 35(c)(4).The required paper copies should be received by the court on or before 12/23/2019 [657963] [19-1368] [Elizabeth Weiswasser] [Entered: 12/19/2019 05:13 PM] (55) |
| Dec 17, 2019 | 62 | Entry of appearance for Sarah M. Sternlieb as of counsel for Appellant Sanofi-Aventis Deutschland GmbH. Service: 12/17/2019 by email. [657268] [19-1368] [Elizabeth Weiswasser] [Entered: 12/17/2019 04:48 PM] (2) |
| Nov 26, 2019 | 61 | ORDER filed. Sanofi's motion to extend time to file rehearing [60] is denied as unnecessary. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [652522] [MJL] [Entered: 11/26/2019 01:50 PM] (2) |
| Nov 25, 2019 | 60 | MOTION of Appellant Sanofi-Aventis Deutschland GmbH to extend the time to file a Combined Petition for Panel Rehearing and Rehearing En Banc until 12/19/2019 [Consent: opposed]. Service: 11/25/2019 by email. [652303] [19-1368] [Elizabeth Weiswasser] [Entered: 11/25/2019 10:33 PM] (11) |
| Nov 20, 2019 | 59 | ERRATA to the Nonprecedential Opinion Doc No.: [57]. Service as of this date by the Clerk of Court. [650763] [19-1368, 19-1369] [JAB] [Entered: 11/20/2019 09:45 AM] (1) |
| Nov 19, 2019 | 58 | JUDGMENT. AFFIRMED. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [650423] [19-1368, 19-1369] [JAB] [Entered: 11/19/2019 09:25 AM] (1) |
| Nov 19, 2019 | 57 | OPINION filed for the court by Newman, Circuit Judge; Taranto, Circuit Judge and Chen, Circuit Judge. Dissenting opinion filed by Circuit Judge Newman. Nonprecedential Opinion. [650422] [19-1368, 19-1369] [JAB] [Entered: 11/19/2019 09:24 AM] (27) |
| Nov 8, 2019 | 56 | Letter from Appellant Sanofi-Aventis Deutschland GmbH in Response to Mylan's Notice Regarding Impending District Court Trial (Dkt. 55). Service: 11/08/2019 by email. [648095] [19-1368] [Elizabeth Weiswasser] [Entered: 11/08/2019 11:42 AM] (3) |
| Nov 6, 2019 | 55 | Letter from Appellee Mylan Pharmaceuticals Inc. Update on status of co-pending district court trial. Service: 11/06/2019 by email. [647255] [19-1368] [Douglas Carsten] [Entered: 11/06/2019 11:22 AM] (2) |
| Nov 6, 2019 | 54 | MODIFIED ENTRY: RESPONSE of Appellee Mylan Pharmaceuticals Inc. to the supplemental authority [52] filed by Appellant Sanofi-Aventis Deutschland GmbH. Service: 11/06/2019 by email. [647249]--[Edited 11/06/2019 by JCA - Reason: to correct filing event] [Douglas Carsten] [Entered: 11/06/2019 11:17 AM] (7) |
| Nov 5, 2019 | 52 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellant Sanofi-Aventis Deutschland GmbH. Service: 11/05/2019 by email. [646907] [19-1368] [Elizabeth Weiswasser] [Entered: 11/05/2019 11:52 AM] (23) |
| Nov 5, 2019 | 53 | Pursuant to Federal Rule of Appellate Procedure 44(a), the court certifies that a party questions the constitutionality of an Act of Congress. See entry [52]. [647097] [MJL] [Entered: 11/05/2019 04:57 PM] (0) |
| Sep 5, 2019 | 51 | Submitted after ORAL ARGUMENT by Adam Banks for Sanofi-Aventis Deutschland GmbH and Douglas H. Carsten for Mylan Pharmaceuticals Inc. Panel: Judge: Newman , Judge: Taranto , Judge: Chen. [633258] [JCP] [Entered: 09/05/2019 10:19 AM] (0) |
| Aug 15, 2019 | 50 | Response to notice of oral argument from the Appellee Mylan Pharmaceuticals Inc.. [628549] [19-1368] [Richard Torczon] [Entered: 08/15/2019 01:20 PM] (3) |
| Aug 15, 2019 | 49 | Response to notice of oral argument from the Appellant Sanofi-Aventis Deutschland GmbH. [628494] [19-1368] [Elizabeth Weiswasser] [Entered: 08/15/2019 11:44 AM] (3) |
| Jul 22, 2019 | 48 | NOTICE OF ORAL ARGUMENT. Panel: 1909H. Case scheduled September 05, 2019 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 402. Response to Notice of Oral Argument due: 08/15/2019. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. [622592] [JAB] [Entered: 07/22/2019 03:23 PM] (2) |
| Jul 18, 2019 | 47 | 6 paper copies of the Confidential Joint Appendix Brief [34] received from Appellant Sanofi-Aventis Deutschland GmbH. [622026] [CJF] [Entered: 07/18/2019 02:44 PM] (0) |
| Jul 18, 2019 | 46 | 6 paper copies of the Reply Brief [32] received from Appellant Sanofi-Aventis Deutschland GmbH. [622025] [CJF] [Entered: 07/18/2019 02:43 PM] (0) |
| Jul 18, 2019 | 45 | 6 paper copies of the Corrected Opening Brief [38] received from Appellant Sanofi-Aventis Deutschland GmbH. [622024] [CJF] [Entered: 07/18/2019 02:43 PM] (0) |
| Jul 17, 2019 | 44 | 6 paper copies of the Opening Response Brief [31] received from Appellee Mylan Pharmaceuticals Inc.. [621559] [CJF] [Entered: 07/17/2019 10:35 AM] (0) |
| Jul 16, 2019 | 43 | Outstanding paper copies of all briefs and appendices must be submitted within three business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(1). [621360] [TAM] [Entered: 07/16/2019 01:59 PM] (0) |
| Jul 15, 2019 | 42 | ORDER filed. The motion [35] is granted to the extent that the appeals will be placed on the September 2019 oral argument calendar. A copy of this order shall be transmitted to the merits panel assigned to these cases.; - FOR CALENDAR.. Service: 07/15/2019 by clerk. [621033] [NL] [Entered: 07/15/2019 02:51 PM] (2) |
| Jul 11, 2019 | 40 | Entry of appearance for Wendy L. Devine as of counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 07/11/2019 by email. [620317] [19-1368] [Richard Torczon] [Entered: 07/11/2019 01:13 PM] (2) |
| Jul 11, 2019 | 41 | REPLY of Appellee Mylan Pharmaceuticals Inc. to response [39]. Service: 07/11/2019 by email. [620442] [19-1368] [Richard Torczon] [Entered: 07/11/2019 06:16 PM] (13) |
| Jul 8, 2019 | 39 | RESPONSE of Appellant Sanofi-Aventis Deutschland GmbH to the motion [35] filed by Appellee Mylan Pharmaceuticals Inc.. Service: 07/08/2019 by email. [619645] [19-1368] [Elizabeth Weiswasser] [Entered: 07/08/2019 06:35 PM] (39) |
| Jun 28, 2019 | 36 | ORDER filed. Any opposition to the motion [35] shall be filed no later than July 8, 2019. Any reply in support of the motion is due no later than July 11, 2019. Service: 06/28/2019 by clerk. [617727] [NL] [Entered: 06/28/2019 11:11 AM] (2) |
| Jun 28, 2019 | 37 | Notice of Correction to the Brief Doc No. [30], Opening Brief Doc No. [30] for Appellant Sanofi-Aventis Deutschland GmbH. Service: 06/28/2019 by email. [617767] [19-1368] [Elizabeth Weiswasser] [Entered: 06/28/2019 12:34 PM] (5) |
| Jun 28, 2019 | 38 | MODIFIED ENTRY: CORRECTED OPENING BRIEF FILED for Appellant Sanofi-Aventis Deutschland GmbH. Number of Pages: 52. Service: 06/28/2019 by email. [617768]--[Edited 07/08/2019 by TAM - compliance review complete] [Elizabeth Weiswasser] [Entered: 06/28/2019 12:37 PM] (183) |
| Jun 27, 2019 | 35 | MOTION of Appellee Mylan Pharmaceuticals Inc. to expedite hearing [Consent: opposed]. Service: 06/27/2019 by email. [617572] [19-1368] [Richard Torczon] [Entered: 06/27/2019 04:29 PM] (94) |
| Jun 25, 2019 | 33 | MODIFIED ENTRY: JOINT APPENDIX FILED for Sanofi-Aventis Deutschland GmbH. Number of Pages: 518. Service: 06/25/2019 by email. [616926] --[Edited 06/28/2019 by TAM - compliance review complete] [Elizabeth Weiswasser] [Entered: 06/25/2019 06:01 PM] (518) |
| Jun 25, 2019 | 34 | MODIFIED ENTRY: CONFIDENTIAL JOINT APPENDIX FILED for Sanofi-Aventis Deutschland GmbH. Number of Pages: 558. Service: 06/25/2019 by email. [616927]--[Edited 06/28/2019 by TAM - compliance review complete] [Elizabeth Weiswasser] [Entered: 06/25/2019 06:12 PM] (0) |
| Jun 18, 2019 | 32 | MODIFIED ENTRY: REPLY BRIEF FILED for Appellant Sanofi-Aventis Deutschland GmbH. Number of Pages: 27. Service: 06/18/2019 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [615309] --[Edited 06/24/2019 by TAM - compliance review complete] [Elizabeth Weiswasser] [Entered: 06/18/2019 07:18 PM] (36) |
| May 28, 2019 | 31 | MODIFIED ENTRY: RESPONSE BRIEF FILED for Appellee Mylan Pharmaceuticals Inc. Number of Pages: 62. Service: 05/28/2019 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [609947] --[Edited 05/31/2019 by TAM - compliance review complete] [Douglas Carsten] [Entered: 05/28/2019 08:17 PM] (75) |
| Apr 26, 2019 | 30 | MODIFIED ENTRY: CORRECTED OPENING BRIEF FILED for Appellant Sanofi-Aventis Deutschland GmbH. Number of Pages: 52. Service: 04/26/2019 by email. [603404] --[Edited 05/01/2019 by TAM - compliance review complete] This brief has been corrected. See Doc No.[38] [Elizabeth Weiswasser] [Entered: 04/26/2019 05:01 PM] (183) |
| Apr 25, 2019 | 29 | Entry of appearance for Andrew Gesior as of counsel for Appellant Sanofi-Aventis Deutschland GmbH. Service: 04/25/2019 by email. [603005] [19-1368] [Elizabeth Weiswasser] [Entered: 04/25/2019 03:40 PM] (2) |
| Apr 25, 2019 | 28 | NOTICE OF NON-COMPLIANCE: The submission of Appellant Sanofi-Aventis Deutschland GmbH, Opening Brief [27], is not in compliance with the rules of this court (see attached). Compliant document due on 05/02/2019. Appellee Mylan Pharmaceuticals Inc.'s brief is due 06/03/2019. Service as of this date by the Clerk of Court.[602933] [TAM] [Entered: 04/25/2019 01:52 PM] (2) |
| Apr 22, 2019 | 27 | FILED from Appellant Sanofi-Aventis Deutschland GmbH. Title: OPENING BRIEF. Service: 04/22/2019 by email. [602162] [19-1368] This document is non-compliant. See Doc No.[28] [Elizabeth Weiswasser] [Entered: 04/22/2019 10:06 PM] (185) |
| Apr 22, 2019 | 26 | Entry of appearance for Adam B. Banks as of counsel for Appellant Sanofi-Aventis Deutschland GmbH. Service: 04/22/2019 by email. [602160] [19-1368] [Elizabeth Weiswasser] [Entered: 04/22/2019 09:56 PM] (2) |
| Mar 29, 2019 | 25 | Entry of appearance for Adam Burrowbridge as of counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 03/29/2019 by email. [596463] [19-1368] [Richard Torczon] [Entered: 03/29/2019 11:00 AM] (2) |
| Mar 28, 2019 | 24 | Entry of appearance for Lora Green as of counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 03/28/2018 by email. [596270] [19-1368] [Richard Torczon] [Entered: 03/28/2019 02:36 PM] (2) |
| Feb 27, 2019 | 23 | Certified list from the United States Patent and Trademark Office. Service: 02/19/2019 by email. Appellant's brief is due 04/22/2019. [589040] [TAM] [Entered: 02/27/2019 12:07 PM] (123) |
| Jan 22, 2019 | 17 | Entry of appearance for Robert T. Vlasis as of counsel for Appellant Sanofi-Aventis Deutschland GmbH. Service: 01/21/2019 by email. [579503] [19-1368] [Elizabeth Weiswasser] [Entered: 01/21/2019 04:16 PM] (2) |
| Jan 22, 2019 | 22 | Docketing Statement for the Appellee Mylan Pharmaceuticals Inc.. Service: 01/22/2019 by email. [579891] [19-1368] [Richard Torczon] [Entered: 01/22/2019 04:35 PM] (4) |
| Jan 22, 2019 | 21 | Certificate of Interest for the Appellee Mylan Pharmaceuticals Inc.. Service: 01/22/2019 by email. [579890] [19-1368] [Richard Torczon] [Entered: 01/22/2019 04:34 PM] (2) |
| Jan 22, 2019 | 20 | Docketing Statement for the Appellant Sanofi-Aventis Deutschland GmbH. Service: 01/21/2019 by email. [579506] [19-1368] [Elizabeth Weiswasser] [Entered: 01/21/2019 04:21 PM] (4) |
| Jan 22, 2019 | 19 | Certificate of Interest for the Appellant Sanofi-Aventis Deutschland GmbH. Service: 01/21/2019 by email. [579505] [19-1368] [Elizabeth Weiswasser] [Entered: 01/21/2019 04:20 PM] (3) |
| Jan 22, 2019 | 18 | Entry of appearance for Aaron L. J. Pereira as of counsel for Appellant Sanofi-Aventis Deutschland GmbH. Service: 01/21/2019 by email. [579504] [19-1368] [Elizabeth Weiswasser] [Entered: 01/21/2019 04:18 PM] (2) |
| Jan 22, 2019 | 16 | Entry of appearance for Anish R. Desai as of counsel for Appellant Sanofi-Aventis Deutschland GmbH. Service: 01/21/2019 by email. [579502] [19-1368] [Elizabeth Weiswasser] [Entered: 01/21/2019 04:14 PM] (2) |
| Jan 22, 2019 | 15 | Entry of appearance for Elizabeth S. Weiswasser as principal counsel for Appellant Sanofi-Aventis Deutschland GmbH. Service: 01/21/2019 by email. [579501] [19-1368] [Elizabeth Weiswasser] [Entered: 01/21/2019 04:12 PM] (2) |
| Jan 18, 2019 | 14 | Entry of appearance for Alina Litoshyk as of counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 01/18/2019 by email. [579374] [19-1368] [Richard Torczon] [Entered: 01/18/2019 02:33 PM] (2) |
| Jan 18, 2019 | 13 | Entry of appearance for Jeffrey W. Guise as of counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 01/18/2019 by email. [579359] [19-1368] [Richard Torczon] [Entered: 01/18/2019 02:13 PM] (2) |
| Jan 18, 2019 | 12 | Entry of appearance for Lorelei Westin as of counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 01/18/2019 by email. [579355] [19-1368] [Richard Torczon] [Entered: 01/18/2019 02:10 PM] (2) |
| Jan 18, 2019 | 11 | Corrected Entry of appearance for Richard Torczon as of counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 01/18/2019 by email. [579255] [19-1368] [Richard Torczon] [Entered: 01/18/2019 10:43 AM] (2) |
| Jan 18, 2019 | 10 | Corrected Entry of appearance for Elham F. Steiner as of counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 01/18/2019 by email. [579252] [19-1368] [Richard Torczon] [Entered: 01/18/2019 10:41 AM] (2) |
| Jan 18, 2019 | 9 | Corrected Entry of appearance for Douglas H. Carsten as principal counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 01/18/2019 by email. [579250] [19-1368] [Richard Torczon] [Entered: 01/18/2019 10:39 AM] (2) |
| Jan 18, 2019 | 8 | Note to file: The following cases are associated: 19-1368 (Lead) with 19-1369 (Member Case). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [579225] [19-1368, 19-1369] [TAM] [Entered: 01/18/2019 09:15 AM] (0) |
| Jan 18, 2019 | 7 | ORDER consolidating appeals (19-1368 with 19-1369). Service as of this date by the Clerk of Court. [579224] [19-1368, 19-1369] [TAM] [Entered: 01/18/2019 09:05 AM] (2) |
| Jan 17, 2019 | 6 | NOTICE OF NON-COMPLIANCE: The submissions of Appellee Mylan Pharmaceuticals Inc., Entry of Appearance for Elham Steiner, Richard Torczon, and Douglas Carsten [4], [3], [2], are not in compliance with the rules of this court (see attached). Compliant document due on 01/25/2019. Service as of this date by the Clerk of Court.[579075] [TAM] [Entered: 01/17/2019 03:48 PM] (2) |
| Jan 16, 2019 | 2 | Entry of appearance for Douglas H. Carsten as principal counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 01/16/2019 by email. [578615] [19-1368] This document is non-compliant. See Doc No. [6] [Richard Torczon] [Entered: 01/16/2019 02:53 PM] (2) |
| Jan 16, 2019 | 5 | Entry of appearance for Nicole W. Stafford as of counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 01/16/2019 by email. [578624] [19-1368] [Richard Torczon] [Entered: 01/16/2019 03:00 PM] (2) |
| Jan 16, 2019 | 4 | Entry of appearance for Elham F. Steiner as of counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 01/16/2019 by email. [578622] [19-1368] This document is non-compliant. See Doc No. [6] [Richard Torczon] [Entered: 01/16/2019 02:58 PM] (2) |
| Jan 16, 2019 | 3 | Entry of appearance for Richard Torczon as of counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 01/16/2019 by email. [578617] [19-1368] This document is non-compliant. See Doc No. [6] [Richard Torczon] [Entered: 01/16/2019 02:55 PM] (2) |
| Jan 7, 2019 | 1 | Appeal docketed. Received: 01/04/2019. [576160] Entry of Appearance due 01/22/2019. Certificate of Interest is due on 01/22/2019. Docketing Statement due 01/22/2019. Certified List due on 02/19/2019. [TAM] [Entered: 01/07/2019 09:58 AM] (57) |
